Common Contracts
11 similar Accelerated Clinical Trial Agreement contracts
Accelerated Clinical Trial AgreementAccelerated Clinical Trial Agreement • January 13th, 2020
{MONTH}, {YEAR} (the “Effective Date”) by and between {INSTITUTION NAME; DESCRIBE INSTITUTION}, a [e.g. non-profit, educational, research, healthcare] institution (“Institution”) with an address at
Accelerated Clinical Trial AgreementAccelerated Clinical Trial Agreement • January 13th, 2020
{MONTH}, {YEAR} (the “Effective Date”) by and between {INSTITUTION NAME; DESCRIBE INSTITUTION}, a [e.g. non-profit, educational, research, healthcare] institution (“Institution”) with an address at
Accelerated Clinical Trial AgreementAccelerated Clinical Trial Agreement • January 13th, 2020
{MONTH}, {YEAR} (the “Effective Date”) by and between {INSTITUTION NAME; DESCRIBE INSTITUTION}, a [e.g. non-profit, educational, research, healthcare] institution (“Institution”) with an address at
International Accelerated Clinical Trial AgreementAccelerated Clinical Trial Agreement • January 13th, 2020 • Delaware
{MONTH}, {YEAR} (the “Effective Date”) by and between {INSTITUTION NAME; DESCRIBE INTITUTION}, a [e.g. non-profit, educational, research, healthcare} institution (“Institution”) with an address at
Accelerated Clinical Trial AgreementAccelerated Clinical Trial Agreement • January 13th, 2020
{MONTH}, {YEAR} (the “Effective Date”) by and between {INSTITUTION NAME; DESCRIBE INSTITUTION}, a [e.g. non-profit, educational, research, healthcare] institution (“Institution”) with an address at {INSTITUTION ADDRESS} and {COMPANY NAME}, a corporation having its principal place of business at {COMPANY ADDRESS} (“Sponsor”). Sponsor and Institution are herein referred to collectively as “Parties.” Individually, each of Sponsor and Institution is a “Party.”
Accelerated Clinical TrialAccelerated Clinical Trial Agreement • December 27th, 2018
ADDRESS} and {COMPANY NAME}, a corporation having its principal place of business at {COMPANY ADDRESS} (“Sponsor”). Sponsor and Institution are herein referred to collectively as “Parties.” Individually, each of Sponsor and Institution is a “Party.”
Accelerated Clinical Trial AgreementAccelerated Clinical Trial Agreement • March 28th, 2017
COMMONWEALTH UNIVERSITY, a non-profit, educational, research and healthcare institution (“Institution”) with an address located at 800 East Leigh Street, Suite 3200, Richmond, Virginia 23298 and
Accelerated Clinical TrialAccelerated Clinical Trial Agreement • September 9th, 2016
ADDRESS} and {COMPANY NAME}, a corporation having its principal place of business at {COMPANY ADDRESS}(“Sponsor”). Sponsor and Institution are herein referred to collectively as “Parties.” Individually, each of Sponsor and Institution is a “Party.”
Accelerated Clinical Trial AgreementAccelerated Clinical Trial Agreement • December 18th, 2014
{MONTH}, {YEAR} (the “Effective Date”) by and between {INSTITUTION NAME}, a non-profit, educational, research and healthcare institution (“Institution”) with an address at {INSTITUTION ADDRESS} and {COMPANY NAME}, a corporation having its principal place of business at {COMPANY ADDRESS}(“Sponsor”). Sponsor and Institution are herein referred to collectively as “Parties.” Individually, each of Sponsor and Institution is a “Party.”
Accelerated Clinical Trial AgreementAccelerated Clinical Trial Agreement • December 18th, 2014
{MONTH}, {YEAR} (the “Effective Date”) by and between {INSTITUTION NAME}, a non-profit, educational, research and healthcare institution (“Institution”) with an address at {INSTITUTION ADDRESS} and {COMPANY NAME}, a corporation having its principal place of business at {COMPANY ADDRESS}(“Sponsor”). Sponsor and Institution are herein referred to collectively as “Parties.” Individually, each of Sponsor and Institution is a “Party.”
Accelerated Clinical Trial AgreementAccelerated Clinical Trial Agreement • December 18th, 2014
{MONTH}, {YEAR} (the “Effective Date”) by and between {INSTITUTION NAME}, a non-profit, educational, research and healthcare institution (“Institution”) with an address at {INSTITUTION ADDRESS} and {COMPANY NAME}, a corporation having its principal place of business at {COMPANY ADDRESS}(“Sponsor”). Sponsor and Institution are herein referred to collectively as “Parties.” Individually, each of Sponsor and Institution is a “Party.”
